Outcome of Board Meeting - Preferential Issue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Achyut Healthcare's board approved multiple items on January 21, 2026, headlined by a preferential allotment of up to 58 lakh equity shares at Rs. 6 each (Rs. 1 face value + Rs. 5 premium), raising up to Rs. 3.48 crore from promoter group entities and non-promoter allottees. The board also cleared an increase in authorised capital from Rs. 24 crore to Rs. 26 crore to facilitate future fundraising, and shifted the registered office within Ahmedabad. The company also filed Q3 FY26 results: revenue of Rs. 157 lakh (down sequentially from Rs. 255 lakh) but 9-month revenue more than tripled to Rs. 721 lakh vs Rs. 213 lakh a year earlier; 9-month net profit was Rs. 23.7 lakh versus Rs. 38.6 lakh in the prior year. An EGM is scheduled for February 19, 2026 to seek shareholder approval. Notably, the stock recently migrated from the BSE SME platform to the BSE Mainboard on January 2, 2026.
The Rs. 3.48 crore preferential issue is small relative to the company's Rs. 2,355 lakh paid-up capital and is largely promoter-driven, so dilution is limited but existing shareholders will see a modest supply increase at a price well above face value. Weak Q3 sequential revenue and profitability, combined with the small fresh equity raise, suggest a small-cap pharma trader in early growth mode; the Mainboard migration could improve liquidity and visibility.